Please find enclosed Investor Presentation on the Q4 FY 25-26 Financial Results
RESULTS
▲ Positive Development
MEDIUM RISK
📅 Filed on BSE: 21 Apr 2026, 06:37 PM IST · BSE ID: 274453d9-1e54-4ce7-859a-e51571299292
View Original BSE Filing (PDF)
💡
In Simple Terms
Tata Elxsi's quarterly revenue hit Rs. 993.8 Cr with strong profit margins; full year crossed Rs. 3,757 Cr with major client wins in automotive and media.
🤖 AI Summary
- Q4 FY26 operating revenue Rs. 993.8 Cr, 4.2% QoQ growth, 9.4% YoY growth
- Full-year FY26 revenue Rs. 3,757.4 Cr at 23.4% PBT margin
- Q4 PBT Rs. 267.8 Cr at 25.6% margin; PAT Rs. 220.4 Cr
- Media & Communications revenue grew 9.5% QoQ; Transportation up 3.6% QoQ
- Strategic wins: Mercedes-Benz SDV partnership, Suzuki Cloud HIL center, Infineon EV collaboration
🔢 Key Numbers — exact figures from BSE filing, not rounded
Q4 FY26 Operating Revenue
Rs. 993.8 Cr
4.2% QoQ, 9.4% YoY
Full-Year FY26 Revenue
Rs. 3,757.4 Cr
Q4 PBT Margin
25.6%
+143 bps QoQ
Q4 PBT
Rs. 267.8 Cr
10.7% QoQ, 20.9% YoY
Q4 PAT
Rs. 220.4 Cr
23.1% QoQ, 27.8% YoY
Full-Year PBT Margin
23.4%
Transportation OEM Revenue Mix
77% of segment
Media & Communications Growth
9.5% QoQ
Transportation Growth
3.6% QoQ
Healthcare Decline
-10.5% QoQ
Constant Currency Revenue Growth
0.9% QoQ, 1.0% YoY
🏢 How This Affects the Company
Transportation segment OEM revenue now accounts for 77% of business, reflecting strategic shift toward software-defined vehicles and OEM-focused engagements. Media & Communications momentum accelerated with 9.5% QoQ growth driven by deal ramp-ups and Tier 1 U.S. Telco win. Multi-year contracts with Mercedes-Benz, Suzuki Motors, and U.S. aerospace suppliers strengthen long-term revenue visibility.
PBT margin expanded 143 basis points QoQ to 25.6%, with PBT growing 10.7% QoQ to Rs. 267.8 Cr. PAT jumped 23.1% QoQ to Rs. 220.4 Cr. Full-year PBT margin of 23.4% demonstrates operational leverage. Constant currency growth of 0.9% QoQ and 1.0% YoY indicates currency headwinds offset organic growth.
Launch of Terumo MedTech Offshore Development Centre expands healthcare segment capacity. Enterprise-wide GenAI adoption via DevStudio.ai and strategic AI partnerships enhance engineering and design delivery capabilities. Partnership with Synopsys enables vECU deployment acceleration for automotive clients.
Healthcare segment declined 10.5% QoQ, signaling concentration risk in that vertical. Constant currency growth significantly lags reported growth, indicating currency volatility impact on margins and revenue recognition. Dependency on multi-year deals with limited near-term visibility into deal extensions.
👥 What This Means For Shareholders
✅
Action Required
No action required. Review presentation for segment performance and track upcoming quarterly results for margin sustainability.
👤
Who Is Affected
All shareholders benefit from margin expansion and strategic contract wins with long-term visibility. Healthcare segment weakness affects investors focused on diversification.
🔍
Management Signal
Focus on design-led and AI-enabled offerings, operational leverage, and sustainable growth indicates management prioritizing profitability over volume growth in maturing transportation segment.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Q1 FY27 results — verify if margin sustains above 23% and Media momentum continues
Transportation segment — track new OEM deal ramp-ups and SDV revenue contribution
Healthcare segment — monitor recovery trajectory and Terumo ODC contribution in next quarter
MEDIUM RISK
Healthcare segment weakness, currency headwinds masking organic growth, and concentration in multi-year OEM contracts create execution and diversification risks.
💡 Investor Takeaway
Q4 FY26 reported revenue Rs. 993.8 Cr with PBT margin 25.6%; full-year revenue Rs. 3,757.4 Cr at 23.4% margin. Constant currency growth flat (0.9% QoQ, 1.0% YoY) signals currency headwind. Strategic automotive wins and 77% OEM revenue concentration strengthen pipeline.
⚖️ Strengths & Concerns
✅ Positives
- PBT margin expanded 143 bps QoQ to 25.6%; full-year margin 23.4% demonstrates sustained profitability
- Transportation OEM revenue 77% of segment; multi-year contracts with Mercedes-Benz and Suzuki Motors secure pipeline
⚠️ Concerns
- Healthcare revenue declined 10.5% QoQ, indicating segment weakness and execution challenges
- Constant currency growth 0.9% QoQ and 1.0% YoY masks currency headwinds impacting financial performance